147 related articles for article (PubMed ID: 22664468)
1. Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers.
Huang H; Mei L; Chu T
Molecules; 2012 Jun; 17(6):6808-20. PubMed ID: 22664468
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
3. Improving tumor/muscle and tumor/blood ratios of
Li S; Chu T
Bioorg Med Chem Lett; 2023 Feb; 82():129154. PubMed ID: 36736496
[TBL] [Abstract][Full Text] [Related]
4. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
5. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies of 99mTc-BnAO and its analogues: synthesis, radiolabeling and in vitro cell uptake.
Sun X; Chu T; Wang X
Nucl Med Biol; 2010 Feb; 37(2):117-23. PubMed ID: 20152710
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers.
Zhang Y; Chu T; Gao X; Liu X; Yang Z; Guo Z; Wang X
Bioorg Med Chem Lett; 2006 Apr; 16(7):1831-3. PubMed ID: 16460938
[TBL] [Abstract][Full Text] [Related]
9.
Lin X; Ruan Q; Zhang X; Duan X; Teng Y; Zhang J
Appl Radiat Isot; 2018 Oct; 140():289-293. PubMed ID: 30092554
[TBL] [Abstract][Full Text] [Related]
10. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a novel (99m)Tc-labeled bioreductive probe for tumor hypoxia imaging.
Kimura S; Umeda IO; Moriyama N; Fujii H
Bioorg Med Chem Lett; 2011 Dec; 21(24):7359-62. PubMed ID: 22078213
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeling of Preformed Niosomes with [
Almasi A; Shahhosseini S; Haeri A; Daha FJ; Geramifar P; Dadashzadeh S
AAPS PharmSciTech; 2018 Nov; 19(8):3859-3870. PubMed ID: 30291544
[TBL] [Abstract][Full Text] [Related]
13. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
14. The biological characterization of (99m)Tc-BnAO-NI as a SPECT probe for imaging hypoxia in a sarcoma-bearing mouse model.
Hsia CC; Huang FL; Hung GU; Shen LH; Chen CL; Wang HE
Appl Radiat Isot; 2011 Apr; 69(4):649-55. PubMed ID: 21236690
[TBL] [Abstract][Full Text] [Related]
15. Preclinical assessment of hypoxic marker specificity and sensitivity.
Iyer RV; Engelhardt EL; Stobbe CC; Schneider RF; Chapman JD
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):741-5. PubMed ID: 9845088
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.
Chu T; Li R; Hu S; Liu X; Wang X
Nucl Med Biol; 2004 Feb; 31(2):199-203. PubMed ID: 15013485
[TBL] [Abstract][Full Text] [Related]
17. Technetium glucose complexes as potential cancer imaging agents.
Dapueto R; Aguiar RB; Moreno M; Machado CM; Marques FL; Gambini JP; Chammas R; Cabral P; Porcal W
Bioorg Med Chem Lett; 2015 Oct; 25(19):4254-9. PubMed ID: 26318991
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
19. In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting.
Sun W; Chu T
Bioorg Med Chem Lett; 2015 Oct; 25(20):4453-6. PubMed ID: 26358160
[TBL] [Abstract][Full Text] [Related]
20. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
